Prevention of ANxiety and Depression Over Risk Assessment
NCT07185867 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2595
Last updated 2025-09-22
Summary
The general goal is to design, develop and evaluate a personalized, self-guided and trans-diagnostic internet-based intervention to prevent anxiety and depression, based on predictive risk algorithms and decision support systems (DSS), in Spanish and Chilean adult population.
Methods: We will conduct a three-arm parallel randomized controlled trial with one year of follow-up. A total of 2,595 depression- or/and anxiety-free participants (865 per group), aged 18-65, will be recruited and randomly assigned to one of two intervention groups or to the usual-care group (in a 1:1:1 ratio). Both interventions, Pandora-1 and Pandora-2, will be implemented via a smartphone application, the Pandora App. Pandora-1 is a self-guided and transdiagnostic intervention that includes 4 interactive intervention modules (move more, sleep better, improve relationships and emotional well-being), as well as predictive risk algorithms, decision support systems, and monitoring and feedback to implement personalized plans for the prevention of anxiety and depression. Pandora-2 is a psycho-educative intervention with predictive risk algorithms, minimally interactive and without personalization. The primary outcome is the combined rate of the onset of anxiety or depression (DSM-V diagnoses as measured by the CIDI interview) at 6 and 12 months. The secondary outcomes are the reduction of depressive (PHQ-9) and anxious (GAD-7) symptoms, risk of depression and anxiety (predictD and predictA risk algorithms), and the improvement of mental \& physical quality of life (SF-12), as well as acceptation and satisfaction with Pandora apps (u-MARS) and adverse effects (ad hoc questionnaire), which will be assessed at 1, 6 and 12 months. As mediators will be measured social support (Duke-UNC-2 items), physical activity (BPAQ-2), sleep (AIS-5), and repetitive negative thinking (PTQ-9) evaluated at 1, 6 and 12 months. We will use ActiGraph-GT3X accelerometers to assess physical activity and sleep at 1 and 6 months, in a subsample of 404 sedentary study participants.
Conditions
- Depression
- Anxiety
- Prevention
- m-Health
Interventions
- BEHAVIORAL
-
Pandora-1 app with high levels of personalization, interaction, monitoring and feedback
Pandora-1 is a behavioral, self-guided and transdiagnostic intervention delivered via an app. It includes predictive risk algorithms, decision support systems (DSS), monitoring and feedback to implement personalized prevention plans (PPP) for anxiety and depression. The intervention has a biopsychosocial approach and offers 4 interactive modules: move more, sleep better, improve relationships and emotional well-being. Participants will receive personalized feedback at baseline, 1, 6 and 12 months, including their levels of depressive and anxiety symptoms over the past two weeks, their predicted risk of developing these disorders in the next year, and related modifiable risk factors (e.g. sedentary lifestyle, insomnia, low social support, poor mental quality of life). Based on this, the app offers suggestions (via DSS) and guides users to relevant content (PPP). Participants follow recommendations of choice, the app tracks these actions and provides feedback at baseline, 1 and 6 months.
- OTHER
-
Pandora-2 app with low levels of personalization, interaction, monitoring and feedback
Pandora-2 is a psychoeducational self-guided and transdiagnostic intervention delivered via an app. This intervention also has a biopsychosocial orientation and includes a set of psychoeducational brochures for the prevention of anxiety and depression that can be used at any time. These read-only brochures will have contents on the same 4 intervention modules (move more, sleep better, improve relationships and emotional well-being). At baseline, 1 and 6, 12 months participants will also receive basic information about their level of depressive and anxiety symptoms over the past two weeks, their risk probability of depressive and anxiety episodes next year and some of their modifiable risk factors associated with such risk (e.g. sedentary lifestyle, insomnia, low social support and poor mental quality of life). However, in Pandora-2 intervention participants will have lower levels of interactive intervention components as suggestions from the DSS about PPP, monitoring and feedback.
Sponsors & Collaborators
-
European Regional Development Fund
collaborator OTHER -
Research Network on Chronicity, Primary Care, and Health Promotion
collaborator UNKNOWN -
Carlos III Health Institute
collaborator OTHER_GOV -
IBIMA Plataforma BIONAD
collaborator UNKNOWN -
Andalusian Regional Ministry of Health
collaborator OTHER_GOV -
The Mediterranean Institute for the Advance of Biotechnology and Health Research
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-02-15
- Primary Completion
- 2028-03-07
- Completion
- 2028-03-07
Countries
- Spain
Study Locations
More Related Trials
-
Post Marketing Study for the Evaluation of Predictix Antidepressant Clinician Software Support Tool in Prescribing Antidepressant Medication/s for the Treatment of Patients Suffering From Major Depressive Disorder
NCT04138290 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Safety and Efficacy of PEER Interactive to Inform Medication Prescription for Subjects With a Primary Diagnosis of Depression
NCT02988076 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment (MedLink)
NCT02583230 ·Status: COMPLETED ·Phase: NA
-
Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical Practice
NCT07009223 ·Status: RECRUITING ·Phase: NA
-
The Efficacy of Automated Feedback After Internet-based Depression Screening
NCT04633096 ·Status: COMPLETED ·Phase: NA
-
Digital Phenotypes for Predicting Depression
NCT07151846 ·Status: ENROLLING_BY_INVITATION
-
Development and Testing of a Behavioral Activation Mobile Therapy for Elevated Depressive Systems
NCT02498132 ·Status: COMPLETED ·Phase: NA
-
Reduction of Cardiovascular Risk in Severe Mental Illness
NCT01182012 ·Status: UNKNOWN ·Phase: PHASE4
-
Remote Evaluation and Alerting for Collaborative Health (REACH) in Depression
NCT07174557 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
NCT06878859 ·Status: RECRUITING ·Phase: NA
-
Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment
NCT01909973 ·Status: COMPLETED ·Phase: NA
-
BIOMARKERS FOR DRUG SELECTION IN DEPRESSION
NCT07269886 ·Status: COMPLETED
-
Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
NCT02330679 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning
NCT05400785 ·Status: COMPLETED ·Phase: NA
-
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
NCT05547035 ·Status: RECRUITING ·Phase: NA
-
Investigating the Effect of a Smartphone-based Serious Game on Depressive Symptoms.
NCT04988529 ·Status: UNKNOWN ·Phase: NA
-
Antidepressant Incomplete Response Depression
NCT00782964 ·Status: COMPLETED
-
Predicting Response to Depression Treatment (PReDicT)
NCT02790970 ·Status: COMPLETED ·Phase: NA
-
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
NCT05537558 ·Status: UNKNOWN
-
Acquisition and Analysis of Relationships Between Longitudinal Emotional Signals Produced by an Artificial Intelligence Algorithm and Self-questionnaires Used in the Psychiatric Follow-up of Patients With Mood and/or Anxiety Disorders: a Real-Environment Study.
NCT05988840 ·Status: UNKNOWN
-
Preventing Depression in Patients With Macular Degeneration
NCT00042211 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Mobile Technology Intervention for the Treatment of Depression
NCT02846662 ·Status: COMPLETED ·Phase: PHASE3
-
Chronobiology and Depression: Circadian Analytics as a Biomarker for Depressive Subtypes
NCT03538275 ·Status: COMPLETED
-
"Prevention and Treatment of Depression in the Elderly: A Population-Based Study"
NCT03538873 ·Status: COMPLETED ·Phase: NA
-
Mood Management Effects of Brief Unsupported Internet Interventions II
NCT02789280 ·Status: COMPLETED ·Phase: NA